|
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
|
The New England journal of medicine |
2016 |
618.9 |
7,145 |
|
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|
Circulation |
2019 |
404.4 |
4,506 |
|
Dietary Advanced Glycation End Products and their Potential role in Cardiometabolic Disease in Children
|
Hormone research in paediatrics |
2016 |
292.6 |
4,018 |
|
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
|
Nature genetics |
2018 |
256.1 |
3,016 |
|
Global vascular guidelines on the management of chronic limb-threatening ischemia
|
Journal of vascular surgery |
2019 |
185.2 |
1,831 |
|
Fine-mapping of an expanded set of type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
|
Nature genetics |
2018 |
139.3 |
1,904 |
|
New genetic loci link adipose and insulin biology to body fat distribution
|
Nature |
2015 |
134.5 |
1,703 |
|
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
|
The New England journal of medicine |
2019 |
125.8 |
1,269 |
|
Genome-wide associations for birth weight and correlations with adult disease
|
Nature |
2016 |
121.7 |
538 |
|
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors
|
Nature genetics |
2019 |
121.1 |
634 |
|
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
|
The New England journal of medicine |
2016 |
115.6 |
1,091 |
|
Diet–microbiota interactions as moderators of human metabolism
|
Nature |
2016 |
103.7 |
2,193 |
|
Oxidative stress, dysfunctional glucose metabolism, and Alzheimer disease
|
Nature reviews. Neuroscience |
2019 |
102.3 |
1,809 |
|
Long term Glycemic Control Using Polymer Encapsulated, Human Stem-Cell Derived β-cells in Immune Competent mice
|
Nature medicine |
2016 |
89.5 |
680 |
|
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
|
Nature medicine |
2019 |
89.2 |
2,159 |
|
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
|
Nature reviews. Neurology |
2018 |
82.0 |
1,476 |
|
The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Preeclampsia (PE): A Pragmatic Guide for First Trimester Screening and Prevention
|
International journal of gynaecology and |
2019 |
80.3 |
1,127 |
|
Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome
|
Nature medicine |
2019 |
74.1 |
822 |
|
Genetic evidence for causal relationships between maternal obesity-related traits and birth weight
|
JAMA |
2016 |
73.9 |
286 |
|
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
|
The New England journal of medicine |
2019 |
71.4 |
944 |
|
Chronic Kidney Disease Diagnosis and Management A Review
|
JAMA |
2019 |
71.2 |
1,678 |
|
Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even Without Weight Loss in Men with Prediabetes
|
Cell metabolism |
2018 |
64.2 |
1,420 |
|
Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents
|
The New England journal of medicine |
2016 |
62.6 |
727 |
|
Type 1 diabetes
|
Lancet (London, England) |
2018 |
61.0 |
1,458 |
|
Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations
|
Circulation |
2016 |
60.8 |
1,104 |
|
Genetics of Blood Lipids Among ~300,000 Multi-Ethnic Participants of the Million Veteran Program
|
Nature genetics |
2018 |
59.4 |
706 |
|
Vitamin D Supplementation and Prevention of Type 2 Diabetes
|
The New England journal of medicine |
2019 |
57.9 |
642 |
|
Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health A Scientific Statement From the American Heart Association
|
Circulation |
2016 |
56.0 |
996 |
|
Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease
|
Journal of hepatology |
2018 |
55.0 |
899 |
|
Celastrol and its Role in Chronic Diseases
|
Advances in experimental medicine and bi |
2016 |
54.2 |
94 |
|
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial
|
JAMA |
2016 |
53.3 |
649 |
|
Childhood and Adolescent Adversity and Cardiometabolic Outcomes A Scientific Statement From the American Heart Association
|
Circulation |
2018 |
53.3 |
487 |
|
Saturated Fat as Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study
|
Journal of the American College of Cardi |
2015 |
51.6 |
521 |
|
Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
|
Cell |
2019 |
51.2 |
1,281 |
|
Heart Failure in Type 2 Diabetes Mellitus: Impact of Glucose Lowering Agents, Heart Failure Therapies and Novel Therapeutic Strategies
|
Circulation research |
2019 |
50.5 |
654 |
|
Association between LDL-cholesterol lowering genetic variants and risk of type 2 diabetes
|
JAMA |
2016 |
50.5 |
415 |
|
Causal relationships between gut microbiome, short-chain fatty acids and metabolic diseases
|
Nature genetics |
2019 |
50.4 |
1,519 |
|
The Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management
|
Circulation |
2018 |
50.2 |
816 |
|
A new era for understanding amyloid structures and disease
|
Nature reviews. Molecular cell biology |
2018 |
48.4 |
988 |
|
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
|
Circulation research |
2016 |
48.1 |
941 |
|
Association between seven years of intensive treatment of type 1 diabetes and long term mortality
|
JAMA |
2015 |
47.0 |
434 |
|
Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management
|
Circulation |
2015 |
45.1 |
234 |
|
Metformin reverses established lung fibrosis in a bleomycin model
|
Nature medicine |
2018 |
44.8 |
566 |
|
ASMBS pediatric metabolic and bariatric surgery guidelines, 2018
|
Surgery for obesity and related diseases |
2018 |
44.6 |
520 |
|
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
|
Current diabetes reports |
2019 |
43.8 |
765 |
|
Three Year Outcomes of Bariatric Surgery vs. Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Trial
|
JAMA surgery |
2015 |
43.4 |
364 |
|
Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity
|
Cell metabolism |
2016 |
43.1 |
837 |
|
Brown and beige fat: Physiological roles beyond heat-generation
|
Cell metabolism |
2015 |
42.1 |
994 |
|
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
|
Diabetologia |
2019 |
40.1 |
456 |
|
Oral Dextrose Gel Reduces the Need for Intravenous Dextrose Therapy in Neonatal Hypoglycemia
|
Biomedicine hub |
2016 |
39.9 |
173 |
|
A Novel Diabetes Prevention Intervention Using a Mobile App A Randomized Controlled Trial With Overweight Adults at Risk
|
American journal of preventive medicine |
2015 |
39.6 |
220 |
|
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
|
Nature genetics |
2018 |
39.6 |
465 |
|
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
|
The lancet. Diabetes & endocrinology |
2019 |
39.2 |
594 |
|
Obesity, kidney dysfunction and hypertension: mechanistic links
|
Nature reviews. Nephrology |
2019 |
38.8 |
604 |
|
Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study
|
The lancet. Diabetes & endocrinology |
2015 |
38.7 |
1,001 |
|
THE SYMPATHETIC NERVOUS SYSTEM ALTERATIONS IN HUMAN HYPERTENSION
|
Circulation research |
2015 |
38.2 |
570 |
|
Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults
|
The New England journal of medicine |
2019 |
38.2 |
351 |
|
Role of Dietary Fructose and Hepatic de novo Lipogenesis in Fatty Liver Disease
|
Digestive diseases and sciences |
2016 |
38.2 |
679 |
|
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice A consensus report of a European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Working Group
|
Bone |
2015 |
37.9 |
466 |
|
Diabetic Cardiomyopathy: What is it and can it be fixed?
|
Circulation research |
2019 |
37.3 |
653 |
|
Aspartate is an endogenous metabolic limitation for tumour growth
|
Nature cell biology |
2018 |
37.2 |
350 |
|
Polypharmacy in the Aging Patient A Review of Glycemic Control in Older Adults With Type 2 Diabetes
|
JAMA |
2016 |
37.2 |
301 |
|
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence A Scientific Statement From the American Heart Association and the American Diabetes Association
|
Circulation |
2015 |
36.6 |
383 |
|
Non-Alcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
|
Cell metabolism |
2018 |
36.1 |
708 |
|
A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes
|
Nature medicine |
2019 |
35.5 |
427 |
|
Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management
|
Current diabetes reports |
2015 |
35.3 |
207 |
|
Potential Overtreatment of Diabetes Mellitus in Older Adults With Tight Glycemic Control
|
JAMA internal medicine |
2015 |
35.1 |
402 |
|
Immune regulation of metabolic homeostasis in health and disease
|
Cell |
2015 |
34.9 |
481 |
|
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
|
Diabetologia |
2016 |
34.9 |
304 |
|
Obesity: Pathophysiology and Management
|
Journal of the American College of Cardi |
2018 |
34.7 |
614 |
|
Managing diabetes with nanomedicine: challenges and opportunities
|
Nature reviews. Drug discovery |
2015 |
34.4 |
594 |
|
Sedentary Behavior and Health: Update from the 2018 Physical Activity Guidelines Advisory Committee
|
Medicine and science in sports and exerc |
2019 |
34.0 |
622 |
|
Update on Medical Overuse
|
JAMA internal medicine |
2016 |
33.9 |
103 |
|
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
|
Nature reviews. Endocrinology |
2018 |
33.8 |
1,334 |
|
Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course
|
Diabetologia |
2019 |
33.3 |
361 |
|
Oxytocin reduces caloric intake in men
|
Obesity (Silver Spring, Md.) |
2015 |
33.2 |
201 |
|
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review
|
Journal of the American College of Cardi |
2018 |
33.1 |
686 |
|
Lipid Fractions and Contrasting Risks of Coronary Artery Disease and Diabetes
|
JAMA cardiology |
2016 |
32.4 |
316 |
|
Exercise Dose in Clinical Practice
|
Circulation |
2016 |
32.2 |
247 |
|
Novel All-Extremity High-Intensity Interval Training Improves Aerobic Fitness, Cardiac Function and Insulin Resistance in Healthy Older Adults
|
Experimental gerontology |
2016 |
32.2 |
143 |
|
Update on management of diabetic foot ulcers
|
Annals of the New York Academy of Scienc |
2018 |
31.7 |
863 |
|
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among People at Increased Risk: A Systematic Review for the Community Preventive Services Task Force
|
Annals of internal medicine |
2015 |
31.5 |
378 |
|
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
|
Journal of hepatology |
2016 |
31.5 |
528 |
|
BCAA catabolism in brown fat controls energy homeostasis through SLC25A44
|
Nature |
2019 |
31.5 |
528 |
|
Comparative effectiveness and cost-effectiveness of target- versus benefit-based treatment of type 2 diabetes in low- and middle-income countries
|
The lancet. Diabetes & endocrinology |
2016 |
31.4 |
39 |
|
Bile acids as metabolic regulators
|
Current opinion in gastroenterology |
2015 |
31.3 |
273 |
|
Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
|
Acta neuropathologica |
2015 |
30.8 |
609 |
|
Sugar consumption, metabolic disease and obesity: The state of the controversy
|
Critical reviews in clinical laboratory |
2016 |
30.2 |
722 |
|
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
|
Diabetologia |
2018 |
30.0 |
863 |
|
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|
American journal of kidney diseases : th |
2018 |
29.8 |
631 |
|
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
|
Nature medicine |
2018 |
29.5 |
987 |
|
High-Intensity Interval Training for Cardiometabolic Disease Prevention
|
Medicine and science in sports and exerc |
2019 |
29.2 |
196 |
|
Fresh Fruit Consumption and Major Cardiovascular Disease in China
|
The New England journal of medicine |
2016 |
29.1 |
286 |
|
Sitagliptin versus placebo in the treatment of nonalcoholic fatty liver disease: A randomized controlled trial
|
Journal of hepatology |
2016 |
28.8 |
321 |
|
Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis
|
Nature genetics |
2018 |
28.8 |
325 |
|
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial
|
The lancet. Diabetes & endocrinology |
2015 |
27.7 |
199 |
|
A Longitudinal Big Data Approach for Precision Health
|
Nature medicine |
2019 |
27.2 |
497 |
|
Type 1 Diabetes in Young Adulthood
|
Current diabetes reviews |
2015 |
27.1 |
194 |
|
Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease
|
JAMA |
2019 |
26.9 |
417 |
|
Empagliflozin and the risk of heart failure hospitalization in routine clinical care: a first analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) Study
|
Circulation |
2019 |
26.9 |
216 |